Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Booster vaccination with messenger RNA (mRNA) vaccines has been offered to adults in England starting on 14 September 2021. We used a test-negative case–control design to estimate the relative effectiveness of a booster dose of BNT162b2 (Pfizer-BioNTech) compared to only a two-dose primary course (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Nick, Stowe, Julia, Kirsebom, Freja, Toffa, Samuel, Sachdeva, Ruchira, Gower, Charlotte, Ramsay, Mary, Lopez Bernal, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018410/
https://www.ncbi.nlm.nih.gov/pubmed/35045566
http://dx.doi.org/10.1038/s41591-022-01699-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018410/
https://www.ncbi.nlm.nih.gov/pubmed/35045566
http://dx.doi.org/10.1038/s41591-022-01699-1

Ejemplares similares